A Study of Solbinsiran (LY3561774) in Participants With Severe Hypertriglyceridemia

Clinical trial NCT07269210 · RECRUITING

Trial details

NCT number: NCT07269210
Sponsor: Eli Lilly and Company
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Severe Hypertriglyceridemia

Start date: 2025-12-08
Primary completion: 2027-03-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.